This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / BioAge Labs Class Action Lawsuit
Business class action lawsuit

BioAge Labs Class Action Lawsuit

Analysis based on 12 articles · First reported Feb 07, 2025 · Last updated Feb 18, 2025

Sentiment
-70
Attention
4
Articles
12
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is negatively impacted by the significant decline in BioAge Labs' stock price, leading to a class action lawsuit. This event highlights the risks associated with pharmaceutical development and potential securities fraud, which can erode investor confidence in the biotechnology sector.

Biotechnology Legal Services
Event Summary

A class action securities lawsuit has been filed against BioAge Labs by Levi & Korsinsky on behalf of investors. The lawsuit alleges securities fraud following BioAge Labs' decision to discontinue its STRIDES Phase 2 trial for azelaprag, its lead product candidate, on December 6, 2024, due to safety concerns regarding elevated liver transaminase levels. This announcement caused BioAge Labs' stock price to plummet from $20.09 to $4.65 per share between December 6 and December 7, 2024. The lawsuit seeks to recover losses for shareholders who purchased stock traceable to BioAge Labs' initial public offering around September 26, 2024.

Key Actions
100 Levi & Korsinsky notified investors BioAge Labs
95 BioAge Labs discontinued trial
90 BioAge Labs issued registration statement
Entities Involved
priv
BioAge Labs
BioAge Labs is facing a class action lawsuit due to alleged securities fraud, stemming from the discontinuation of its lead product candidate's Phase 2 trial, which caused a significant drop in its stock price.
Importance 100.0 Sentiment -90.0
index
Nasdaq-100
Nasdaq-100 is the stock exchange where BioAge Labs' shares are traded, and where its stock price declined following the news.
Importance 10.0 Sentiment 0.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
per
Joseph E. Levi
Importance 0.0 Sentiment 0.0
Relationships
Levi & Korsinsky related ↔ Joseph E. Levi
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.